Chronic obstructive pulmonary disease and cardiovascular mortality in elderly subjects from general population

Abstract Aims. To ascertain whether chronic obstructive pulmonary disease (COPD) is an independent risk factor for cardiovascular (CV) mortality in the elderly subjects from general population. Methods. 3282 subjects of the Northern Italy aged ≥65 years were followed up for 12 years in the frame of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Blood pressure 2010, Vol.19 (2), p.67-74
Hauptverfasser: Mazza, Alberto, Zamboni, Sergio, Rubello, Domenico, Schiavon, Laura, Zorzan, Sara, Casiglia, Edoardo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 74
container_issue 2
container_start_page 67
container_title Blood pressure
container_volume 19
creator Mazza, Alberto
Zamboni, Sergio
Rubello, Domenico
Schiavon, Laura
Zorzan, Sara
Casiglia, Edoardo
description Abstract Aims. To ascertain whether chronic obstructive pulmonary disease (COPD) is an independent risk factor for cardiovascular (CV) mortality in the elderly subjects from general population. Methods. 3282 subjects of the Northern Italy aged ≥65 years were followed up for 12 years in the frame of the CArdiovascular STtudy in the ELderly. Multivariate stepwise proportional hazard Cox regression was therefore used to identify the prognostic role of COPD on CV mortality in hypertensive (HT) and normotensive (NT) subjects. The hazard ratio (HR) of COPD with 95% confidence interval (CI) for mortality was adjusted for confounders in both genders. Results. COPD resulted to be an independent predictor of CV mortality (HR 1.34, CI 1.13-1.61) in HT but not in NT subjects. This was evident both in men (HR 1.44, 1.25-1.95) and women (HR 1.32, CI 1.14-1.53); pulse pressure (PP) was directly related and anti-hypertensive therapy inversely related to risk of CV mortality, an association that was greater in subjects with than without COPD. Conclusion. COPD should be included in the computation of global risk in HT subjects. PP is the main BP component in increasing CV risk in subjects with COPD. Controlled trials should be performed to evaluate the pressor targets to be reached in HT subjects with COPD, with the aim of decreasing their CV risk.
doi_str_mv 10.3109/08037050903464642
format Article
fullrecord <record><control><sourceid>proquest_infor</sourceid><recordid>TN_cdi_proquest_miscellaneous_733855896</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>733855896</sourcerecordid><originalsourceid>FETCH-LOGICAL-c514t-9f720c6939b678cfb37d15ffd4f25d068b2bffa5ea95d1db3a4145ab5dbfe0423</originalsourceid><addsrcrecordid>eNp9kM2KFDEUhYM4OO3oA7iR7FyVJpVKVQXdSOMfDMxmZl3c_NlpUkl7k5qh395qehRElCxu4H7nIzmEvOLsreBMvWMjEwOTTDHR9etpn5AN7yVvuFLqKdmc9s0K8EvyvJQ9Y1wIxp6Ry5ad7kpsSNruMKdgaNal4mJquHf0sMQ5J8AjtaE4KI5CstQA2pDvoZglAtI5Y4UY6pGGRF20DuORlkXvnamFeswz_e6SQ4j0kFcj1JDTC3LhIRb38nFekbvPn263X5vrmy_fth-vGyN5Vxvlh5aZXgml-2E0XovBcum97XwrLetH3WrvQTpQ0nKrBXS8k6Cl1d6xrhVX5M3Ze8D8Y3GlTnMoxsUIyeWlTIMQo5Sj6leSn0mDuRR0fjpgmNe_T5xNp5anv1peM68f7Yuenf2d-FXrCnw4AyH5jDM8ZIx2qnCMGT1CMqGc3P_2v_8jvnMQ627t3037vGBam_vP634CP0qgUw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733855896</pqid></control><display><type>article</type><title>Chronic obstructive pulmonary disease and cardiovascular mortality in elderly subjects from general population</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Mazza, Alberto ; Zamboni, Sergio ; Rubello, Domenico ; Schiavon, Laura ; Zorzan, Sara ; Casiglia, Edoardo</creator><creatorcontrib>Mazza, Alberto ; Zamboni, Sergio ; Rubello, Domenico ; Schiavon, Laura ; Zorzan, Sara ; Casiglia, Edoardo</creatorcontrib><description>Abstract Aims. To ascertain whether chronic obstructive pulmonary disease (COPD) is an independent risk factor for cardiovascular (CV) mortality in the elderly subjects from general population. Methods. 3282 subjects of the Northern Italy aged ≥65 years were followed up for 12 years in the frame of the CArdiovascular STtudy in the ELderly. Multivariate stepwise proportional hazard Cox regression was therefore used to identify the prognostic role of COPD on CV mortality in hypertensive (HT) and normotensive (NT) subjects. The hazard ratio (HR) of COPD with 95% confidence interval (CI) for mortality was adjusted for confounders in both genders. Results. COPD resulted to be an independent predictor of CV mortality (HR 1.34, CI 1.13-1.61) in HT but not in NT subjects. This was evident both in men (HR 1.44, 1.25-1.95) and women (HR 1.32, CI 1.14-1.53); pulse pressure (PP) was directly related and anti-hypertensive therapy inversely related to risk of CV mortality, an association that was greater in subjects with than without COPD. Conclusion. COPD should be included in the computation of global risk in HT subjects. PP is the main BP component in increasing CV risk in subjects with COPD. Controlled trials should be performed to evaluate the pressor targets to be reached in HT subjects with COPD, with the aim of decreasing their CV risk.</description><identifier>ISSN: 0803-7051</identifier><identifier>EISSN: 1651-1999</identifier><identifier>DOI: 10.3109/08037050903464642</identifier><identifier>PMID: 20001393</identifier><language>eng</language><publisher>England: Informa UK Ltd. (Informa Healthcare, Taylor &amp; Francis AS)</publisher><subject>Aged ; Antihypertensive Agents - therapeutic use ; Arterial hypertension ; Cardiovascular Diseases - drug therapy ; Cardiovascular Diseases - mortality ; chronic obstructive pulmonary disease ; elderly ; Female ; Humans ; Hypertension - drug therapy ; Hypertension - mortality ; Hypertension - physiopathology ; Male ; mortality ; Prognosis ; Pulmonary Disease, Chronic Obstructive - drug therapy ; Pulmonary Disease, Chronic Obstructive - mortality ; Risk Factors</subject><ispartof>Blood pressure, 2010, Vol.19 (2), p.67-74</ispartof><rights>Informa UK Ltd 2010</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c514t-9f720c6939b678cfb37d15ffd4f25d068b2bffa5ea95d1db3a4145ab5dbfe0423</citedby><cites>FETCH-LOGICAL-c514t-9f720c6939b678cfb37d15ffd4f25d068b2bffa5ea95d1db3a4145ab5dbfe0423</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,4009,27902,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20001393$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mazza, Alberto</creatorcontrib><creatorcontrib>Zamboni, Sergio</creatorcontrib><creatorcontrib>Rubello, Domenico</creatorcontrib><creatorcontrib>Schiavon, Laura</creatorcontrib><creatorcontrib>Zorzan, Sara</creatorcontrib><creatorcontrib>Casiglia, Edoardo</creatorcontrib><title>Chronic obstructive pulmonary disease and cardiovascular mortality in elderly subjects from general population</title><title>Blood pressure</title><addtitle>Blood Press</addtitle><description>Abstract Aims. To ascertain whether chronic obstructive pulmonary disease (COPD) is an independent risk factor for cardiovascular (CV) mortality in the elderly subjects from general population. Methods. 3282 subjects of the Northern Italy aged ≥65 years were followed up for 12 years in the frame of the CArdiovascular STtudy in the ELderly. Multivariate stepwise proportional hazard Cox regression was therefore used to identify the prognostic role of COPD on CV mortality in hypertensive (HT) and normotensive (NT) subjects. The hazard ratio (HR) of COPD with 95% confidence interval (CI) for mortality was adjusted for confounders in both genders. Results. COPD resulted to be an independent predictor of CV mortality (HR 1.34, CI 1.13-1.61) in HT but not in NT subjects. This was evident both in men (HR 1.44, 1.25-1.95) and women (HR 1.32, CI 1.14-1.53); pulse pressure (PP) was directly related and anti-hypertensive therapy inversely related to risk of CV mortality, an association that was greater in subjects with than without COPD. Conclusion. COPD should be included in the computation of global risk in HT subjects. PP is the main BP component in increasing CV risk in subjects with COPD. Controlled trials should be performed to evaluate the pressor targets to be reached in HT subjects with COPD, with the aim of decreasing their CV risk.</description><subject>Aged</subject><subject>Antihypertensive Agents - therapeutic use</subject><subject>Arterial hypertension</subject><subject>Cardiovascular Diseases - drug therapy</subject><subject>Cardiovascular Diseases - mortality</subject><subject>chronic obstructive pulmonary disease</subject><subject>elderly</subject><subject>Female</subject><subject>Humans</subject><subject>Hypertension - drug therapy</subject><subject>Hypertension - mortality</subject><subject>Hypertension - physiopathology</subject><subject>Male</subject><subject>mortality</subject><subject>Prognosis</subject><subject>Pulmonary Disease, Chronic Obstructive - drug therapy</subject><subject>Pulmonary Disease, Chronic Obstructive - mortality</subject><subject>Risk Factors</subject><issn>0803-7051</issn><issn>1651-1999</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kM2KFDEUhYM4OO3oA7iR7FyVJpVKVQXdSOMfDMxmZl3c_NlpUkl7k5qh395qehRElCxu4H7nIzmEvOLsreBMvWMjEwOTTDHR9etpn5AN7yVvuFLqKdmc9s0K8EvyvJQ9Y1wIxp6Ry5ad7kpsSNruMKdgaNal4mJquHf0sMQ5J8AjtaE4KI5CstQA2pDvoZglAtI5Y4UY6pGGRF20DuORlkXvnamFeswz_e6SQ4j0kFcj1JDTC3LhIRb38nFekbvPn263X5vrmy_fth-vGyN5Vxvlh5aZXgml-2E0XovBcum97XwrLetH3WrvQTpQ0nKrBXS8k6Cl1d6xrhVX5M3Ze8D8Y3GlTnMoxsUIyeWlTIMQo5Sj6leSn0mDuRR0fjpgmNe_T5xNp5anv1peM68f7Yuenf2d-FXrCnw4AyH5jDM8ZIx2qnCMGT1CMqGc3P_2v_8jvnMQ627t3037vGBam_vP634CP0qgUw</recordid><startdate>2010</startdate><enddate>2010</enddate><creator>Mazza, Alberto</creator><creator>Zamboni, Sergio</creator><creator>Rubello, Domenico</creator><creator>Schiavon, Laura</creator><creator>Zorzan, Sara</creator><creator>Casiglia, Edoardo</creator><general>Informa UK Ltd. (Informa Healthcare, Taylor &amp; Francis AS)</general><general>Taylor &amp; Francis</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>2010</creationdate><title>Chronic obstructive pulmonary disease and cardiovascular mortality in elderly subjects from general population</title><author>Mazza, Alberto ; Zamboni, Sergio ; Rubello, Domenico ; Schiavon, Laura ; Zorzan, Sara ; Casiglia, Edoardo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c514t-9f720c6939b678cfb37d15ffd4f25d068b2bffa5ea95d1db3a4145ab5dbfe0423</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Aged</topic><topic>Antihypertensive Agents - therapeutic use</topic><topic>Arterial hypertension</topic><topic>Cardiovascular Diseases - drug therapy</topic><topic>Cardiovascular Diseases - mortality</topic><topic>chronic obstructive pulmonary disease</topic><topic>elderly</topic><topic>Female</topic><topic>Humans</topic><topic>Hypertension - drug therapy</topic><topic>Hypertension - mortality</topic><topic>Hypertension - physiopathology</topic><topic>Male</topic><topic>mortality</topic><topic>Prognosis</topic><topic>Pulmonary Disease, Chronic Obstructive - drug therapy</topic><topic>Pulmonary Disease, Chronic Obstructive - mortality</topic><topic>Risk Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mazza, Alberto</creatorcontrib><creatorcontrib>Zamboni, Sergio</creatorcontrib><creatorcontrib>Rubello, Domenico</creatorcontrib><creatorcontrib>Schiavon, Laura</creatorcontrib><creatorcontrib>Zorzan, Sara</creatorcontrib><creatorcontrib>Casiglia, Edoardo</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Blood pressure</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mazza, Alberto</au><au>Zamboni, Sergio</au><au>Rubello, Domenico</au><au>Schiavon, Laura</au><au>Zorzan, Sara</au><au>Casiglia, Edoardo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Chronic obstructive pulmonary disease and cardiovascular mortality in elderly subjects from general population</atitle><jtitle>Blood pressure</jtitle><addtitle>Blood Press</addtitle><date>2010</date><risdate>2010</risdate><volume>19</volume><issue>2</issue><spage>67</spage><epage>74</epage><pages>67-74</pages><issn>0803-7051</issn><eissn>1651-1999</eissn><abstract>Abstract Aims. To ascertain whether chronic obstructive pulmonary disease (COPD) is an independent risk factor for cardiovascular (CV) mortality in the elderly subjects from general population. Methods. 3282 subjects of the Northern Italy aged ≥65 years were followed up for 12 years in the frame of the CArdiovascular STtudy in the ELderly. Multivariate stepwise proportional hazard Cox regression was therefore used to identify the prognostic role of COPD on CV mortality in hypertensive (HT) and normotensive (NT) subjects. The hazard ratio (HR) of COPD with 95% confidence interval (CI) for mortality was adjusted for confounders in both genders. Results. COPD resulted to be an independent predictor of CV mortality (HR 1.34, CI 1.13-1.61) in HT but not in NT subjects. This was evident both in men (HR 1.44, 1.25-1.95) and women (HR 1.32, CI 1.14-1.53); pulse pressure (PP) was directly related and anti-hypertensive therapy inversely related to risk of CV mortality, an association that was greater in subjects with than without COPD. Conclusion. COPD should be included in the computation of global risk in HT subjects. PP is the main BP component in increasing CV risk in subjects with COPD. Controlled trials should be performed to evaluate the pressor targets to be reached in HT subjects with COPD, with the aim of decreasing their CV risk.</abstract><cop>England</cop><pub>Informa UK Ltd. (Informa Healthcare, Taylor &amp; Francis AS)</pub><pmid>20001393</pmid><doi>10.3109/08037050903464642</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0803-7051
ispartof Blood pressure, 2010, Vol.19 (2), p.67-74
issn 0803-7051
1651-1999
language eng
recordid cdi_proquest_miscellaneous_733855896
source MEDLINE; EZB-FREE-00999 freely available EZB journals
subjects Aged
Antihypertensive Agents - therapeutic use
Arterial hypertension
Cardiovascular Diseases - drug therapy
Cardiovascular Diseases - mortality
chronic obstructive pulmonary disease
elderly
Female
Humans
Hypertension - drug therapy
Hypertension - mortality
Hypertension - physiopathology
Male
mortality
Prognosis
Pulmonary Disease, Chronic Obstructive - drug therapy
Pulmonary Disease, Chronic Obstructive - mortality
Risk Factors
title Chronic obstructive pulmonary disease and cardiovascular mortality in elderly subjects from general population
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T06%3A14%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_infor&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Chronic%20obstructive%20pulmonary%20disease%20and%20cardiovascular%20mortality%20in%20elderly%20subjects%20from%20general%20population&rft.jtitle=Blood%20pressure&rft.au=Mazza,%20Alberto&rft.date=2010&rft.volume=19&rft.issue=2&rft.spage=67&rft.epage=74&rft.pages=67-74&rft.issn=0803-7051&rft.eissn=1651-1999&rft_id=info:doi/10.3109/08037050903464642&rft_dat=%3Cproquest_infor%3E733855896%3C/proquest_infor%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=733855896&rft_id=info:pmid/20001393&rfr_iscdi=true